Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."

NCT07686107 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: Revumenib
DRUG: Fludarabine
DRUG: Cytarabine (Ara-C)
DRUG: Methotrexate (IT)
DRUG: Hydrocortisone (intrathecal)
DRUG: Cytarabine (intrathecal)

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium